SCHEMBL4906208

SCHEMBL4906208

CCN(c1nc(-c2ccc(C(C)(C)C)cc2)sc1C)S(=O)(=O)c1ccc(C(C)C)c(C(=O)O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
HPGD P15428 2/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41
LMNA P02545 1/20 0.39
TRPM8 Q7Z2W7 4/20 0.39
HCRTR2 O43614 1/20 0.38
MAPT P10636 2/20 0.36
HDAC3 O15379 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
KMT2A Q03164 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
KEAP1 Q14145 1/20 0.35
NFE2L2 Q16236 1/20 0.35
BCL2L1 Q07817 4/20 0.35
MCL1 Q07820 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4898146 0.92 LMNA (0.41) ALDH1A1HPGDALOX15HSD17B10LMNA
SCHEMBL4908496 0.92 ALDH1A1 (0.44) ALDH1A1HPGDALOX15HSD17B10LMNA
SCHEMBL4895904 0.91 ALDH1A1 (0.39) ALDH1A1HPGDLMNATRPM8HCRTR2
SCHEMBL4904191 0.90 LMNA (0.42) ALDH1A1HPGDALOX15HSD17B10LMNA
SCHEMBL4905802 0.90 LMNA (0.45) ALDH1A1HPGDALOX15HSD17B10LMNA
SCHEMBL4907195 0.89 LMNA (0.39) ALDH1A1HPGDALOX15HSD17B10LMNA
SCHEMBL4906402 0.89 LMNA (0.39) ALDH1A1HPGDALOX15HSD17B10LMNA
SCHEMBL4905813 0.87 TRPM8 (0.50) TRPM8
SCHEMBL4907500 0.85 TRPM8 (0.39) ALDH1A1HPGDALOX15HSD17B10LMNA
SCHEMBL4906947 0.85 LMNA (0.46) ALDH1A1HPGDALOX15HSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD ALDH1A1 2956/4885HPGD 724/4885ALOX15 1494/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ALDH1A1 2956/4885HPGD 724/4885ALOX15 1494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.